Question. Isn't phase 2 study still primarily a safety study.
Actual improvement which is sustained has very interesting implications. Suggests the treatment is more than just neuroprotective. Astonishing if true. I wonder if they have had the chance to examine the brain of one of the early subjects yet?
Question. Isn't phase 2 study still primarily a safety study....
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.001(10.0%) |
Mkt cap ! $18.56M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 1.0¢ | $2.942K | 271.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 3488858 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 1690169 | 11 |
View Market Depth
| Last trade - 14.17pm 01/07/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |